Page last updated: 2024-09-05

dabigatran and Angiogenesis, Pathologic

dabigatran has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, CC; Hou, MC; Hsieh, YC; Hsu, WF; Huang, YH; Lee, KC; Lin, HC; Yang, YY	1

Other Studies

1 other study(ies) available for dabigatran and Angiogenesis, Pathologic

Article	Year
Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats. Digestive diseases and sciences, 2019, Volume: 64, Issue:1 Topics: Animals; Antithrombins; Cell Line; Chemical and Drug Induced Liver Injury; Collagen; Cytoprotection; Dabigatran; Extracellular Signal-Regulated MAP Kinases; Fibrin; Hepatic Stellate Cells; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Neovascularization, Pathologic; Phosphorylation; Portal Pressure; Rats, Sprague-Dawley; Thioacetamide	2019

Article

Year

Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.

Digestive diseases and sciences, 2019, Volume: 64, Issue:1

Topics: Animals; Antithrombins; Cell Line; Chemical and Drug Induced Liver Injury; Collagen; Cytoprotection; Dabigatran; Extracellular Signal-Regulated MAP Kinases; Fibrin; Hepatic Stellate Cells; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Neovascularization, Pathologic; Phosphorylation; Portal Pressure; Rats, Sprague-Dawley; Thioacetamide

2019